Diversified Trust Co Buys 26,232 Shares of Colgate-Palmolive (NYSE:CL)

Diversified Trust Co grew its stake in shares of Colgate-Palmolive (NYSE:CL) by 48.2% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 80,614 shares of the company’s stock after purchasing an additional 26,232 shares during the period. Diversified Trust Co’s holdings in Colgate-Palmolive were worth $7,259,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. Regal Investment Advisors LLC lifted its stake in shares of Colgate-Palmolive by 1.6% in the 4th quarter. Regal Investment Advisors LLC now owns 7,574 shares of the company’s stock valued at $604,000 after purchasing an additional 121 shares during the period. M&G Investment Management Ltd. increased its holdings in Colgate-Palmolive by 0.3% in the 4th quarter. M&G Investment Management Ltd. now owns 49,269 shares of the company’s stock worth $3,942,000 after acquiring an additional 125 shares in the last quarter. Wealthcare Advisory Partners LLC increased its holdings in Colgate-Palmolive by 3.9% in the 4th quarter. Wealthcare Advisory Partners LLC now owns 3,404 shares of the company’s stock worth $271,000 after acquiring an additional 127 shares in the last quarter. &PARTNERS increased its holdings in Colgate-Palmolive by 0.7% in the 4th quarter. &PARTNERS now owns 17,643 shares of the company’s stock worth $1,406,000 after acquiring an additional 129 shares in the last quarter. Finally, AMG National Trust Bank increased its holdings in Colgate-Palmolive by 0.4% in the 4th quarter. AMG National Trust Bank now owns 30,232 shares of the company’s stock worth $2,410,000 after acquiring an additional 131 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Down 0.3 %

NYSE:CL traded down $0.25 during mid-day trading on Monday, hitting $96.79. The stock had a trading volume of 1,204,491 shares, compared to its average volume of 4,480,291. The stock has a 50-day simple moving average of $93.87 and a two-hundred day simple moving average of $87.63. The company has a market capitalization of $79.41 billion, a PE ratio of 30.78, a PEG ratio of 3.57 and a beta of 0.39. Colgate-Palmolive has a twelve month low of $67.62 and a twelve month high of $99.08. The company has a current ratio of 1.06, a quick ratio of 0.70 and a debt-to-equity ratio of 13.21.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, April 26th. The company reported $0.86 earnings per share for the quarter, beating the consensus estimate of $0.82 by $0.04. The firm had revenue of $5.07 billion for the quarter, compared to analysts’ expectations of $4.96 billion. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. The firm’s revenue was up 6.2% compared to the same quarter last year. During the same quarter last year, the company earned $0.73 earnings per share. On average, equities research analysts anticipate that Colgate-Palmolive will post 3.53 EPS for the current year.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, August 15th. Shareholders of record on Friday, July 19th will be paid a $0.50 dividend. The ex-dividend date of this dividend is Friday, July 19th. This represents a $2.00 annualized dividend and a yield of 2.07%. Colgate-Palmolive’s dividend payout ratio is currently 63.29%.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, insider John W. Kooyman sold 3,497 shares of the stock in a transaction that occurred on Tuesday, May 7th. The shares were sold at an average price of $93.47, for a total value of $326,864.59. Following the transaction, the insider now directly owns 3,181 shares in the company, valued at $297,328.07. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, insider Sally Massey sold 12,226 shares of the stock in a transaction on Thursday, May 9th. The stock was sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the completion of the sale, the insider now directly owns 13,924 shares of the company’s stock, valued at $1,309,691.44. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider John W. Kooyman sold 3,497 shares of the stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $93.47, for a total value of $326,864.59. Following the sale, the insider now directly owns 3,181 shares of the company’s stock, valued at $297,328.07. The disclosure for this sale can be found here. 0.37% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the stock. Morgan Stanley boosted their price target on shares of Colgate-Palmolive from $101.00 to $103.00 and gave the stock an “overweight” rating in a report on Tuesday, May 28th. Citigroup upped their target price on shares of Colgate-Palmolive from $95.00 to $100.00 and gave the stock a “buy” rating in a report on Tuesday, April 16th. Barclays upped their target price on shares of Colgate-Palmolive from $84.00 to $85.00 and gave the stock an “equal weight” rating in a report on Tuesday, April 30th. Evercore ISI upped their target price on shares of Colgate-Palmolive from $90.00 to $96.00 and gave the stock an “outperform” rating in a report on Monday, April 8th. Finally, Wells Fargo & Company upped their price objective on shares of Colgate-Palmolive from $90.00 to $92.00 and gave the company an “equal weight” rating in a report on Monday, April 29th. Three investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat, Colgate-Palmolive presently has an average rating of “Moderate Buy” and an average target price of $93.83.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.